142 related articles for article (PubMed ID: 12417178)
1. Toxic characteristics of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) nanospheres; in vitro and in vivo studies in the normal mice.
Kim SY; Lee YM; Baik DJ; Kang JS
Biomaterials; 2003 Jan; 24(1):55-63. PubMed ID: 12417178
[TBL] [Abstract][Full Text] [Related]
2. Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(epsilon-caprolactone) as novel anticancer drug carriers.
Kim SY; Lee YM
Biomaterials; 2001 Jul; 22(13):1697-704. PubMed ID: 11396872
[TBL] [Abstract][Full Text] [Related]
3. Indomethacin-loaded methoxy poly(ethylene glycol)/ poly(epsilon-caprolactone) diblock copolymeric nanosphere: pharmacokinetic characteristics of indomethacin in the normal Sprague-Dawley rats.
Kim SY; Lee YM; Shin HJ; Kang JS
Biomaterials; 2001 Jul; 22(14):2049-56. PubMed ID: 11426885
[TBL] [Abstract][Full Text] [Related]
4. Indomethacin-loaded methoxy poly(ethylene glycol)/poly(D,L-lactide) amphiphilic diblock copolymeric nanospheres: pharmacokinetic and toxicity studies in rodents.
Kim SY; Lee YM; Kang JS
J Biomed Mater Res A; 2005 Sep; 74(4):581-90. PubMed ID: 16025473
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of biodegradable nanospheres composed of methoxy poly(ethylene glycol) and DL-lactide block copolymer as novel drug carriers.
Kim SY; Shin IG; Lee YM
J Control Release; 1998 Dec; 56(1-3):197-208. PubMed ID: 9801443
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs.
Park EK; Lee SB; Lee YM
Biomaterials; 2005 Mar; 26(9):1053-61. PubMed ID: 15369694
[TBL] [Abstract][Full Text] [Related]
7. Amphiphilic diblock copolymeric nanospheres composed of methoxy poly(ethylene glycol) and glycolide: properties, cytotoxicity and drug release behaviour.
Kim SY; Shin IG; Lee YM
Biomaterials; 1999 Jun; 20(11):1033-42. PubMed ID: 10378803
[TBL] [Abstract][Full Text] [Related]
8. Copolymer micelles and nanospheres with different in vitro stability demonstrate similar paclitaxel pharmacokinetics.
Letchford K; Burt HM
Mol Pharm; 2012 Feb; 9(2):248-60. PubMed ID: 22204437
[TBL] [Abstract][Full Text] [Related]
9. Methoxy poly(ethylene glycol) and epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. II. Micelle formation and drug release behaviours.
Kim SY; Shin IG; Lee YM; Cho CS; Sung YK
J Control Release; 1998 Jan; 51(1):13-22. PubMed ID: 9685900
[TBL] [Abstract][Full Text] [Related]
10. In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles.
Letchford K; Liggins R; Wasan KM; Burt H
Eur J Pharm Biopharm; 2009 Feb; 71(2):196-206. PubMed ID: 18762253
[TBL] [Abstract][Full Text] [Related]
11. Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide)/poly(epsilon-caprolactone) (PCL) amphiphilic block copolymeric nanospheres. II. Thermo-responsive drug release behaviors.
Kim SY; Ha JC; Lee YM
J Control Release; 2000 Apr; 65(3):345-58. PubMed ID: 10699293
[TBL] [Abstract][Full Text] [Related]
12. The combined use of paclitaxel-loaded nanoparticles with a low-molecular-weight copolymer inhibitor of P-glycoprotein to overcome drug resistance.
Wan CP; Letchford K; Jackson JK; Burt HM
Int J Nanomedicine; 2013; 8():379-91. PubMed ID: 23378760
[TBL] [Abstract][Full Text] [Related]
13. Poly(ethylene glycol)/poly(epsilon-caprolactone) diblock copolymeric nanoparticles for non-viral gene delivery: the role of charge group and molecular weight in particle formation, cytotoxicity and transfection.
Jang JS; Kim SY; Lee SB; Kim KO; Han JS; Lee YM
J Control Release; 2006 Jun; 113(2):173-82. PubMed ID: 16750279
[TBL] [Abstract][Full Text] [Related]
14. Methoxy poly(ethylene glycol)-block-poly(delta-valerolactone) copolymer micelles for formulation of hydrophobic drugs.
Lee H; Zeng F; Dunne M; Allen C
Biomacromolecules; 2005; 6(6):3119-28. PubMed ID: 16283736
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of effects of sustained anti-TNF release from MPEG-PCL-MPEG and PCL microspheres on human rheumatoid arthritis synoviocytes.
Erdemli Ö; Özen S; Keskin D; Usanmaz A; Batu ED; Atilla B; Tezcaner A
J Biomater Appl; 2014 Oct; 29(4):524-42. PubMed ID: 24854983
[TBL] [Abstract][Full Text] [Related]
16. Acute toxicity evaluation of in situ gel-forming controlled drug delivery system based on biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymer.
Fang F; Gong CY; Dong PW; Fu SZ; Gu YC; Guo G; Zhao X; Wei YQ; Qian ZY
Biomed Mater; 2009 Apr; 4(2):025002. PubMed ID: 19208940
[TBL] [Abstract][Full Text] [Related]
17. Methoxy poly(ethylene glycol)/epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterization.
Shin IG; Kim SY; Lee YM; Cho CS; Sung YK
J Control Release; 1998 Jan; 51(1):1-11. PubMed ID: 9685899
[TBL] [Abstract][Full Text] [Related]
18. Etoposide-loaded biodegradable amphiphilic methoxy (poly ethylene glycol) and poly (epsilon caprolactone) copolymeric micelles as drug delivery vehicle for cancer therapy.
Mohanty AK; Dilnawaz F; Mohanty C; Sahoo SK
Drug Deliv; 2010 Jul; 17(5):330-42. PubMed ID: 20370380
[TBL] [Abstract][Full Text] [Related]
19. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
[TBL] [Abstract][Full Text] [Related]
20. In vivo fate of unimers and micelles of a poly(ethylene glycol)-block-poly(caprolactone) copolymer in mice following intravenous administration.
Liu J; Zeng F; Allen C
Eur J Pharm Biopharm; 2007 Mar; 65(3):309-19. PubMed ID: 17257817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
